A recently conducted trial shows Pfizer Inc (NYSE:PFE) and BioNTech SE – ADR (NASDAQ:BNTX) Covid-19 vaccine to be working. The two companies seem quite happy with the vaccine’s effectiveness, and they want the European Medicines Agency to expand its usage. The European Medicines Agency will decide whether or not the vaccine will be administered to teenagers.
Pfizer targets expanded use
Pfizer exudes great confidence in the vaccine and wants the body to approve its usage among adolescents aged 12 to 15. Most of the available vaccines have only been approved for adult use, and the push for an expanded usage rages on.
The first clinical test consisted of about 2,000 participants, and the outcomes turned out rather impressive. The vaccine staged 100% effectiveness in fighting illnesses among children. The two companies seem quite pleased because of the impressive teen tolerance to the vaccine. These two companies look forward to great times ahead, hoping that teens will take advantage of the vaccine’s strong response.
Pfizer and BioNTech continue hoping that The European Medicines Agency will make the right move to ensure that more people benefit. They have been pushing the body to expand their license to reach out to more areas within the United States. The two companies also disclose that they will continue pushing for further amendments and speak out to more regulators worldwide.
Offering support for the re-opening of schools
The fall school opening nears, and if the companies want to support a safer and smoother re-opening of schools. The companies also want to reduce the risks of infection by a significant margin. Many companies seeking to help the world deal with the deadly scourge continue carrying out a series of tests to determine the vaccine’s effectiveness among children.
Most parents don’t seem enthusiastic about the vaccination of children. Indeed, children don’t face major risks, but most parents don’t seem to be embracing children’s vaccination. The government has been calling out for full cooperation during the first vaccination wave among children. It hopes that children will take the shot to make them stronger against the virus.